Magstim Logo

Magstim Awarded FDA (510K) Clearance for Advanced Transcranial Magnetic Stimulation (TMS) Platform Horizon 3.0

Magstim Horizon 3.0 system

New Class of Navigated TMS Delivers Customized, Repeatable Treatments Improving Patient Care and Clinical Efficiencies

MINNEAPOLIS, Minn. & Carmarthenshire, UK — (Oct. 28, 2021) – Magstim, the global leader in neuroscience research and treatment for mental health, has been awarded 510K clearance for Horizon 3.0. Designed specifically for the clinical setting, Horizon 3.0 offers enhanced workflows with navigated TMS and analytics. Magstim Connect is a new powerful patient data management system for TMS delivering connected care at all networked sites. 

“We spoke with physicians, patients, researchers and employees and asked them to imagine the next-generation of TMS technology,” said Lothar Krinke, PhD, CEO Magstim. “How can we improve patient care efficacy and efficiencies? Horizon 3.0 is the culmination of Magstim’s foundation in science, technology and our passion to improve patient outcomes. We look forward to bringing Horizon 3.0 to psychiatrists and clinicians throughout the US who are helping patients with treatment resistant depression. This is a major step in the evolution of care for mental health.”

Magstim developed the first TMS system more than 30 years ago and there have been close to 16,000 published studies citing the use of Magstim Stimulators in neuroscientific and clinical research.

TMS is a form of non-invasive brain stimulation that uses an electromagnetic coil to stimulate nerve cells in the region of the brain involved in mood control and depression.

Horizon 3.0 integrates Magstim StimGuide+, which adds new layers of quality control analytics and workflow improvements to the first FDA-cleared TMS navigation system that was designed specifically for the clinical setting.

Magstim Connect is an advanced new patient data management system for TMS delivering consistent connected care at all networked sites. Clinicians can remotely manage patient protocols, analyze treatment outcomes and synchronize data between multiple devices on a HIPAA compliant cloud platform.

“Our TMS patients have experienced a high-degree of success, allowing them to change their lives,” said Khaled Bowarshi, M.D., Florida TMS Clinic.  We strive to provide the best technology for our patients. I have first-hand experience test driving all the TMS systems on the market. I can now with confidence crown Magstim’s Horizon 3.0 with StimGuide + to be the best TMS system on the market today.”

This FDA clearance allows Magstim to bring Horizon 3.0 to thousands of physicians and clinicians in the USA. Plans are in development to bring H3 to global locations.

Keep up to date

By signing up you are confirming that you have read, understood and accept our Privacy Policy